Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F

Class:IdLiteratureReference:192231
_displayNameDifferential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F
_timestamp2007-01-30 13:52:04
author[Person:192232] Tian, C
[Person:180560] Yu, X
[Person:175912] Zhang, W
[Person:192227] Wang, Tao
[Person:192228] Xu, R
[Person:180559] Yu, Xiao-Fang
created[InstanceEdit:192230] Matthews, L, 2007-01-30 13:51:34
journalJ Virol
pages3112-5
pubMedIdentifier16501124
titleDifferential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F
volume80
year2006
(literatureReference)[Summation:180734] The HIV-1 Vif protein associates with the DNA editing enzyme...
[Change default viewing format]
No pathways have been reviewed or authored by Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F (192231)